These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 8999121)

  • 61. Predictive modeling of insulin release profile from cross-linked chitosan microspheres.
    Jose S; Fangueiro JF; Smitha J; Cinu TA; Chacko AJ; Premaletha K; Souto EB
    Eur J Med Chem; 2013 Feb; 60():249-53. PubMed ID: 23313633
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Preparation and Properties of 5-Fluorouracil-Loaded Chitosan Microspheres for the Intranasal Administration.
    Li W; Ba H; Huang P; Zheng A; Yang X
    Drug Res (Stuttg); 2018 Dec; 68(12):673-679. PubMed ID: 29966151
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Preparation and characterization of a biodegradable drug targeting system for anticancer drug delivery: microsphere-antibody conjugate.
    Muvaffak A; Gurhan I; Gunduz U; Hasirci N
    J Drug Target; 2005 Apr; 13(3):151-9. PubMed ID: 16036303
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Methotrexate loaded chitosan and chitin microspheres--in vitro characterization and pharmacokinetics in mice bearing Ehrlich ascites carcinoma.
    Singh UV; Udupa N
    J Microencapsul; 1998; 15(5):581-94. PubMed ID: 9743914
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Controlled release of interleukin-2 from chitosan microspheres.
    Ozbaş-Turan S; Akbuğa J; Aral C
    J Pharm Sci; 2002 May; 91(5):1245-51. PubMed ID: 11977100
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Chitosan microspheres prepared by spray drying.
    He P; Davis SS; Illum L
    Int J Pharm; 1999 Sep; 187(1):53-65. PubMed ID: 10502613
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Crosslinked chitosan microspheres for encapsulation of diclofenac sodium: effect of crosslinking agent.
    Kumbar SG; Kulkarni AR; Aminabhavi M
    J Microencapsul; 2002; 19(2):173-80. PubMed ID: 11837972
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Design of phosphated cross-linked microspheres of bael fruit gum as a biodegradable carrier.
    Mahammed N; Gowda DV; Deshpande RD; Thirumaleshwar S
    Arch Pharm Res; 2015 Jan; 38(1):42-51. PubMed ID: 24668152
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Chitosan/cellulose acetate microspheres preparation and ranitidine release in vitro.
    Zhou HY; Chen XG; Liu CS; Meng XH; Yu LJ; Liu XY; Liu N
    Pharm Dev Technol; 2005; 10(2):219-25. PubMed ID: 15926670
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The influence of chitosan on in vitro properties of Eudragit RS microspheres.
    Kriznar B; Mateović T; Bogataj M; Mrhar A
    Chem Pharm Bull (Tokyo); 2003 Apr; 51(4):359-64. PubMed ID: 12672985
    [TBL] [Abstract][Full Text] [Related]  

  • 71. 5-Fluorouracil encapsulated alginate beads for the treatment of breast cancer.
    Arica B; Caliş S; Kaş H; Sargon M; Hincal A
    Int J Pharm; 2002 Aug; 242(1-2):267-9. PubMed ID: 12176261
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Optimization of the formulation design of chitosan microspheres containing cisplatin.
    Wang YM; Sato H; Adachi I; Horikoshi I
    J Pharm Sci; 1996 Nov; 85(11):1204-10. PubMed ID: 8923326
    [TBL] [Abstract][Full Text] [Related]  

  • 73. In vitro 5-fluorouracil release properties investigation from pH sensitive sodium alginate coated and uncoated methyl cellulose/chitosan microspheres.
    Olukman Şahin M; Şanlı O
    Int J Biol Macromol; 2024 Feb; 258(Pt 1):128895. PubMed ID: 38141696
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Preparation and in vitro drug release performance of morphine-loaded chitosan microspheres].
    Li YL; Liao JH; Hu DH; Chen WB; Zhou CR; Lu L; Rong JH
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Mar; 30(3):490-3. PubMed ID: 20335117
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Preparation and release characteristics of cisplatin albumin microspheres containing chitin and treated with chitosan.
    Nishioka Y; Kyotani S; Masui H; Okamura M; Miyazaki M; Okazaki K; Ohnishi S; Yamamoto Y; Ito K
    Chem Pharm Bull (Tokyo); 1989 Nov; 37(11):3074-7. PubMed ID: 2632057
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Preparation and clinical application of polyvinyl alcohol/drug-loaded chitosan microsphere composite wound dressing].
    Zhang X; Lin Z; Chen W; Song Y; Li Z
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2011 Apr; 28(2):381-6. PubMed ID: 21604506
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Porous chitosan microsphere for controlling the antigen release of Newcastle disease vaccine: preparation of antigen-adsorbed microsphere and in vitro release.
    Mi FL; Shyu SS; Chen CT; Schoung JY
    Biomaterials; 1999 Sep; 20(17):1603-12. PubMed ID: 10482415
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Nanoparticles based on the complex of chitosan and polyaspartic acid sodium salt: preparation, characterization and the use for 5-fluorouracil delivery.
    Zheng Y; Yang W; Wang C; Hu J; Fu S; Dong L; Wu L; Shen X
    Eur J Pharm Biopharm; 2007 Nov; 67(3):621-31. PubMed ID: 17533123
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Preparation of casein-chitosan microspheres containing diltiazem hydrochloride by an aqueous coacervation technique.
    Bayomi MA; al-Suwayeh SA; el-Helw AM; Mesnad AF
    Pharm Acta Helv; 1998 Dec; 73(4):187-92. PubMed ID: 9861867
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Two-stage optimization process for formulation of chitosan microspheres.
    Dubey RR; Parikh RH
    AAPS PharmSciTech; 2004 Feb; 5(1):E5. PubMed ID: 15198526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.